These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27113197)

  • 1. Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C.
    Duan L; Yan Y; Liu J; Wang B; Li P; Hu Q; Chen W
    Sci Rep; 2016 Apr; 6():24867. PubMed ID: 27113197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Target delivery of small interfering RNAs with vitamin E- loaded lipid nanoparticles in inhibition of hepatitis C virus core protein expression in mouse model].
    Ye YY; Chen H; Yan Y; Chen L; Huang WX
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):382-387. PubMed ID: 29996208
    [No Abstract]   [Full Text] [Related]  

  • 3. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
    Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
    Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.
    Kim SI; Shin D; Lee H; Ahn BY; Yoon Y; Kim M
    J Hepatol; 2009 Mar; 50(3):479-88. PubMed ID: 19155084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNAs targeting the rabies virus nucleoprotein gene.
    Yang YJ; Zhao PS; Zhang T; Wang HL; Liang HR; Zhao LL; Wu HX; Wang TC; Yang ST; Xia XZ
    Virus Res; 2012 Oct; 169(1):169-74. PubMed ID: 22884777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.
    Chandra PK; Kundu AK; Hazari S; Chandra S; Bao L; Ooms T; Morris GF; Wu T; Mandal TK; Dash S
    Mol Ther; 2012 Sep; 20(9):1724-36. PubMed ID: 22617108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I.
    Kim SI; Shin D; Choi TH; Lee JC; Cheon GJ; Kim KY; Park M; Kim M
    Mol Ther; 2007 Jun; 15(6):1145-52. PubMed ID: 17440441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.
    Watanabe T; Umehara T; Yasui F; Nakagawa S; Yano J; Ohgi T; Sonoke S; Satoh K; Inoue K; Yoshiba M; Kohara M
    J Hepatol; 2007 Dec; 47(6):744-50. PubMed ID: 17822798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
    Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
    Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?
    Abo-Zeid Y; Urbanowicz RA; Thomson BJ; Irving WL; Tarr AW; Garnett MC
    Int J Pharm; 2018 Aug; 547(1-2):572-581. PubMed ID: 29908332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral delivery of small interfering RNAs (siRNAs) using adenoviral vector protects mice against lethal peripheral rabies challenge.
    Gupta PK; Sonwane AA; Singh NK; Meshram CD; Dahiya SS; Pawar SS; Gupta SP; Chaturvedi VK; Saini M
    Virus Res; 2012 Jan; 163(1):11-8. PubMed ID: 21864591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.
    Khaliq S; Jahan S; Ijaz B; Ahmad W; Asad S; Pervaiz A; Samreen B; Khan M; Hassan S
    Virol J; 2010 Nov; 7():318. PubMed ID: 21073745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of short interfering RNAs on hepatitis C Virus 5' untranslated region expression].
    Chen ZJ; Zhang LH; Li W; Liu X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):319-21. PubMed ID: 18322589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of hepatitis C virus gene expression by antisense nucleotide in vitro].
    Li YN; Yu M; Wu WQ; Gao JX; Wang H; Ji SP; Wang QH; Si CW
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):341-3. PubMed ID: 15650784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2.
    Moon JS; Lee SH; Han SH; Kim EJ; Cho H; Lee W; Kim MK; Kim TE; Park HJ; Rhee JK; Kim SJ; Cho SW; Han SH; Oh JW
    Nanomedicine; 2016 Aug; 12(6):1489-98. PubMed ID: 27013134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.
    Lee J; Saw PE; Gujrati V; Lee Y; Kim H; Kang S; Choi M; Kim JI; Jon S
    Theranostics; 2016; 6(2):192-203. PubMed ID: 26877778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.